エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of March 2026
Commission File Number: 001-42213
WeRide Inc.
21st Floor, Tower A, Guanzhou Life Science Innovation Center
No. 51, Luoxuan Road, Guangzhou International Biotech Island
Guangzhou 510005
People’s Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
INCORPORATION BY REFERENCE
This Report on Form 6-K, including Exhibit 99.1 hereto, shall be deemed to be incorporated by reference into the registration statements on Form S-8 (Registration Nos. 333-286106 and 333-294551) and the registration statement on Form F-3ASR (Registration No. 333-291214) of WeRide Inc. (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.
Resignation of Non-Executive Director
Mr. Kazuhiro Doi (“Mr. Doi”), a non-executive director of WeRide Inc. (the “Company”) previously nominated by Alliance Ventures, B.V., has tendered his resignation from the Board of Directors (the “Board”) of the Company due to retirement, effective March 31, 2026. Mr. Doi has confirmed that he has no disagreement with the Board and there is no matter in relation to his resignation that needs to be brought to the attention of the shareholders of the Company. The Board would like to express its sincere gratitude to Mr. Doi for his valuable contribution to the Company during his tenure of office.
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Announcement—List of Directors and their Roles and Functions |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| WeRide Inc. | ||
| By: | /s/ Jennifer Li | |
| Name: | Jennifer Li | |
| Title: | Chief Financial Officer | |
Date: March 31, 2026
Exhibit 99.1
WeRide Inc.
文遠知行*
(A company controlled through weighted voting rights and incorporated in the Cayman Islands with limited liability)
(Stock code: 0800)
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
The members of the board (the “Board”) of directors (the “Directors”) of WeRide Inc. are set out below.
Executive Directors
Dr. Tony Xu Han (韓旭) (Chairman and Chief Executive Officer)
Dr. Yan Li (李岩)
Non-executive Director
Mr. Jean-François Salles
Independent non-executive Directors
Ms. Huiping Yan
Mr. David Zhang (張彤)
Dr. Tony Fan-cheong Chan
Our Board has four committees. The table below provides membership information of these committees on which each Director serves.
| Board Committee | Corporate | |||
| Audit | Compensation | Nomination | Governance | |
| Director | Committee | Committee | Committee | Committee |
| Dr. Tony Xu Han (韓旭) | Member | Member | ||
| Dr. Yan Li (李岩) | ||||
| Mr. Jean-François Salles | ||||
| Ms. Huiping Yan | Chairperson | Member | Member | Member |
| Mr. David Zhang (張彤) | Member | Chairperson | Chairperson | Chairperson |
| Dr. Tony Fan-cheong Chan | Member | Member | Member | Member |
March 31, 2026
* For identification purposes only